Metelimumab
Metelimumab (CAT-192) is a human IgG4 monoclonal antibody that can selectively neutralize TGFβ1[1].
Product Specifications
CAS Number
[272780-74-2]
Product Name Alternative
CAT-192; Anti-TGFB1 Recombinant Antibody
UNSPSC
12352203
Target
TGF-β Receptor
Type
Inhibitory Antibodies
Related Pathways
TGF-beta/Smad
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/metelimumab.html
Purity
98.98
Solubility
H2O
Smiles
[Metelimumab]
Molecular Weight
(145.02 kDa)
References & Citations
[1]Lord DM, et, al. Structure-based engineering to restore high affinity binding of an isoform-selective anti-TGFβ1 antibody. MAbs. 2018 Apr;10 (3) :444-452.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1124870-01 0.02 mg (E-Coli)
Recombinant Lycosa singoriensis Toxin-like structure LSTX-D5
Ask
View Details 
MBS1124870-02 0.1 mg (E-Coli)
Recombinant Lycosa singoriensis Toxin-like structure LSTX-D5
Ask
View Details 
MBS1124870-03 0.02 mg (Yeast)
Recombinant Lycosa singoriensis Toxin-like structure LSTX-D5
Ask
View Details 
MBS1124870-04 0.1 mg (Yeast)
Recombinant Lycosa singoriensis Toxin-like structure LSTX-D5
Ask
View Details MBS1124870-05 0.02 mg (Baculovirus)
Recombinant Lycosa singoriensis Toxin-like structure LSTX-D5
Ask
View Details MBS1124870-06 1 mg (E-Coli)
Recombinant Lycosa singoriensis Toxin-like structure LSTX-D5
Ask
View Details